Yidong Zhao
About Yidong Zhao
Yidong Zhao is a QC Scientist at Bristol Myers Squibb in Bothell, Washington, with extensive experience in various analytical methods and a background in Neuroendocrinology from Tianjin Medical University.
Company
Yidong Zhao is currently working at Bristol Myers Squibb (BMS) as a QC Scientist in Bothell, Washington, United States. Prior to this, Zhao held positions at Juno Therapeutics, Inc., Dendreon, and Amgen, among others. His extensive career in quality control (QC) spans across several well-known companies in the biotech and pharmaceutical industries.
Title
Yidong Zhao holds the position of QC Scientist at Bristol Myers Squibb. In this capacity, he applies his in-depth knowledge of analytical methods and quality control to ensure the reliability and accuracy of product testing and validation.
Education and Expertise
Yidong Zhao studied at Tianjin Medical University, where he specialized in Neuroendocrinology and received a Master of Science (MS) degree. His expertise includes the creation of Empower3 methods using Agilent and Waters systems, proficiency in HPLC and UPLC systems, skill in CE-SDS for reducing and non-reducing gels using 32 Karat software on the PA800 system, and experience with iCIEF using the ProteinSimple system. Zhao is also skilled in conducting cell-based bioassays, viral titer determination assays, binding assays, NuPAGE, and peptide mapping.
Background
Yidong Zhao has a robust background in quality control, beginning as a QC, Sr. Associate at Amgen from 2002 to 2007 in Bothell, WA. He subsequently worked at Dendreon as a QC, Sr. Associate from 2009 to 2016. Zhao joined BMS Seattle as QC Scientist I from 2016 to 2017 before moving to Juno Therapeutics, Inc. where he served as a QC Specialist from 2017 to 2022. His extensive professional history underscores his long-standing dedication to enhancing quality control processes in the pharmaceutical and biotechnology sectors.
Achievements
Throughout his career, Yidong Zhao has acquired broad expertise in various analytical techniques and methods. This includes hands-on experience with Empower3 for method creation, HPLC and UPLC systems, CE-SDS using 32 Karat software, and iCIEF with ProteinSimple systems. His work has been instrumental in conducting cell-based bioassays, viral titer determination assays, binding assays, NuPAGE, and peptide mapping within a GMP environment, contributing significantly to the quality control efforts in his respective roles.